Open AccessArticle10.7175/rhc.v3i2.203

Biosimilars and patient safety risk: promoting policy protections in the health delivery system

Bryan A. Liang,Tim K. Mackey-2012-04-20-Reviews in Health Care

2

Chat with Paper

AI Agents for this Paper

No abstract available for this paper.

Keywords

BiosimilarMedicineRisk analysis (engineering)Environmental healthInternal medicine

Chat

Click to start Chat